| Literature DB >> 24445999 |
Shuan Rao1, Luigi Tortola1, Thomas Perlot1, Gerald Wirnsberger1, Maria Novatchkova1, Roberto Nitsch1, Peter Sykacek2, Lukas Frank3, Daniel Schramek1, Vukoslav Komnenovic1, Verena Sigl1, Karin Aumayr1, Gerald Schmauss1, Nicole Fellner4, Stephan Handschuh5, Martin Glösmann5, Pawel Pasierbek1, Michaela Schlederer6, Guenter P Resch4, Yuting Ma7, Heng Yang7, Helmuth Popper8, Lukas Kenner6, Guido Kroemer9, Josef M Penninger1.
Abstract
Autophagy is a mechanism by which starving cells can control their energy requirements and metabolic states, thus facilitating the survival of cells in stressful environments, in particular in the pathogenesis of cancer. Here we report that tissue-specific inactivation of Atg5, essential for the formation of autophagosomes, markedly impairs the progression of KRas(G12D)-driven lung cancer, resulting in a significant survival advantage of tumour-bearing mice. Autophagy-defective lung cancers exhibit impaired mitochondrial energy homoeostasis, oxidative stress and a constitutively active DNA damage response. Genetic deletion of the tumour suppressor p53 reinstates cancer progression of autophagy-deficient tumours. Although there is improved survival, the onset of Atg5-mutant KRas(G12D)-driven lung tumours is markedly accelerated. Mechanistically, increased oncogenesis maps to regulatory T cells. These results demonstrate that, in KRas(G12D)-driven lung cancer, Atg5-regulated autophagy accelerates tumour progression; however, autophagy also represses early oncogenesis, suggesting a link between deregulated autophagy and regulatory T cell controlled anticancer immunity.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24445999 DOI: 10.1038/ncomms4056
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919